Home > Schedule >
Detailed Program
¨ç Clinical Research Methodology Course -Intermediate course
(6¿ù 25ÀÏ Åä¿äÀÏ 10:00~17:00, ¸óÅ׷μÒ)
<1ºÎ>
10:00~10:50
Statistical modeling for continuous outcome
¼Û±âÁØ(¿¬¼¼ÀÇ´ë ¼¼ºê¶õ½ºº´¿ø)
- Single and multiple linear regression analysis
10:50-11:00
Q&A, Break
11:00-11:50
Statistical modeling for binary outcome
¼Û±âÁØ(¿¬¼¼ÀÇ´ë ¼¼ºê¶õ½ºº´¿ø)
- Single and multiple logistic regression analysis
11:50-12:00
Q&A, Break
12:00-13:00
Á¡½É½Ä»ç
<2ºÎ>
13:00-13:50
Statistical modeling for time-to-event outcome (I)
¼Û±âÁØ(¿¬¼¼ÀÇ´ë ¼¼ºê¶õ½ºº´¿ø)
- Kaplan-Meier estimation of survival function
- Comparison of survival curves
13:50-14:00
Q&A, Break
14:00-14:50
Statistical modeling for time-to-event outcome (II)
¼Û±âÁØ(¿¬¼¼ÀÇ´ë ¼¼ºê¶õ½ºº´¿ø)
- Cox's proportional hazard regression analysis
14:50-15:00
Q&A, Break
15:00-15:50
Fundametals of sample size calculation
¼Û±âÁØ(¿¬¼¼ÀÇ´ë ¼¼ºê¶õ½ºº´¿ø)
- Concept/basic principles of sample size estimation
- Typical examples: independent/paired mean comparsion, independent/paired proportion comparison, etc
15:50-16:00
Q&A, Break
16:00-16:50
Basics of systematic review and meta-analysis of diagnostic test accuracy studies
ÃÖ»óÇö (¿ï»êÀÇ´ë ¼¿ï¾Æ»êº´¿ø)
- Systematic review ¹× meta-analysisÀÇ ÀϹÝÀûÀÎ ¹æ¹ý·Ð¿¡ ´ëÇÑ °³³ä
- Diagnostic test accuracy studyÀÇ meta-analysis¿Í ÀϹÝÀûÀÎ meta-analysisÀÇ Â÷ÀÌÁ¡ ¹× ÀüÀÚ¿¡ Æ¯ÈµÈ ¹æ¹ý·Ð ¼³¸í
16:50-17:00
Q&A, Break
¨è º¹ºÎ¿µ»ó Áõ·Ê (6¿ù 25ÀÏ
Åä¿äÀÏ 09:00-11:50, ¸¶³ª·Ñ¶ó)
<1ºÎ> º¹ºÎ¿µ»ó Áõ·Ê ¥° (À§Àå°ü)
ÁÂÀå: ÀÌÁØ¿ì(¾ç»êºÎ»ê´ëÇб³º´¿ø), Á¤¿ë¿¬(ȼøÀü³²´ëÇб³º´¿ø)
09:00-09:20
º¹ºÎ Áõ·Ê 1, 2
ÀÌ¿¹´Ù¿î(ÀÎÁ¦ÀÇ´ë ÇØ¿î´ë¹éº´¿ø)
09:20-09:40
º¹ºÎ Áõ·Ê 3, 4
À̳²°æ(ºÎ»ê´ëÇб³º´¿ø)
09:40-09:50
º¹ºÎ Áõ·Ê 5
¼´ÏÀº(¿¬¼¼ÀÇ´ë ¼¼ºê¶õ½ºº´¿ø)
09:50-10:00
ÈÞ½Ä
<2ºÎ> º¹ºÎ¿µ»ó Áõ·Ê ¥± (°£, ´ã³¶)
ÁÂÀå: ÀÌ¿µÈ¯(¿ø±¤´ëÇб³º´¿ø), ÀåÀçõ(¿µ³²´ëÇб³º´¿ø)
10:00-10:20
º¹ºÎ Áõ·Ê 6, 7
ÃÖÁÖ¿Ï(´ë±¸ÆÄƼ¸¶º´¿ø)
10:20-10:40
º¹ºÎ Áõ·Ê 8, 9
°¿õ·¡(´ë±¸°¡Å縯´ëÇб³º´¿ø)
10:40-10:50
º¹ºÎ Áõ·Ê 10
°Å¿í(¼º±Õ°üÀÇ´ë »ï¼º¼¿ïº´¿ø)
10:50-11:00
ÈÞ½Ä
<3ºÎ> º¹ºÎ¿µ»ó Áõ·Ê ¥² (´ã°ü, ÃéÀå, ±âŸ)
ÁÂÀå: ¿À°æ½Â(°í½Å´ëÇб³ º¹À½º´¿ø), À±±ÇÇÏ(¿ø±¤´ëÇб³º´¿ø)
11:00-11:20
º¹ºÎ Áõ·Ê 11, 12
¹ÚÁ¤±¸(°í½Å´ëÇб³ º¹À½º´¿ø)
11:20-11:40
º¹ºÎ Áõ·Ê 13, 14
±ÇÈñÁø(µ¿¾Æ´ëÇб³º´¿ø)
11:40-11:50
º¹ºÎ Áõ·Ê 15
¼ÛÁö¼ö(ÀüºÏ´ëÇб³º´¿ø)
¨é RANK-QS Symposium (6¿ù 25ÀÏ Åä¿äÀÏ 09:00-17:00, º£¸£³ªÂ÷)
ºÎÁ¦: ÀÇ·á¹æ»ç¼± ¾ÈÀü°ü¸®
<1ºÎ> ¹æ»ç¼±¾ÈÀü°ü¸® ½ÇÀü¸Å´º¾ó
ÁÂÀå: ¼ºµ¿¿í(°æÈñ´ëÇб³º´¿ø)
09:00-09:25
¿ì¸®º´¿ø ±â±â ¹æ»ç¼±·®Àº ¾î¶»°Ô ¾Ë ¼ö ÀÖ³ª¿ä?
ÃÖ¹®Çü(°¡Å縯ÀÇ´ë ¼¿ï¼º¸ðº´¿ø)
- ÀϹÝÃÔ¿µ, Åõ½Ã, CT
09:25-09:50
ȯÀÚµéÀÌ ±Ã±ÝÇØ ÇÏ´Â ¹æ»ç¼± °Ë»ç Áö½Ä: ´Ùºóµµ ¹®´äÇ®ÀÌ
À±¼øÈ£(¼¿ï´ëÇб³º´¿ø)
09:50-10:15
½Ã¼úÀÚ(ÀÇ·áÁø) º¸È£¸¦ À§ÇÑ ¿øÄ¢
¾î È«(¼º±Õ°üÀÇ´ë »ï¼º¼¿ïº´¿ø)
10:15-10:20
Q&A
10:20-10:40
ÈÞ½Ä
<2ºÎ> ÀÇ·á¹æ»ç¼± °ü¸® ¹æÇâ
ÁÂÀå: µµ°æÇö(¿ï»êÀÇ´ë ¼¿ï¾Æ»êº´¿ø)
10:40-11:10
¿ì¸®³ª¶ó ÀÇ·á¹æ»ç¼± °ü¸® Á¤Ã¥ ¹æÇâ
ÀÌ°Èñ(Áúº´°ü¸®º»ºÎ ÀÇ·á¹æ»ç¼±°ú)
11:10-12:00
ÁöÁ¤Åä·Ð
- °³¿ø°¡ÀÇ ÀÇ·á¹æ»ç¼±°ü¸®
ÀÌâ¼®(ÀÌÁö¿µ»óÀÇÇаú)
- ¼±·®°ü¸® ÇÁ·Î±×·¥ »ç¿ë °æÇè
ȲÀ翬(¾ç»êºÎ»ê´ëÇб³º´¿ø)
- ¼±·®°ü¸® ±³À°ÀÇ Çʿ伺
¿ìÇö½Ä(¼¿ï½Ã¸³ º¸¶ó¸Åº´¿ø)
- ±¸Ã¼Àû ¼±·®°ü¸® ½ÃÇà¹æÇâ
ÃÖÁØÀÏ(°¡Å縯ÀÇ´ë ¼¿ï¼º¸ðº´¿ø)
12:00-13:30
Á¡½É
ºÎÁ¦: ¿µ»óÀÇÇÐ º¸Çè °ü·Ã Á¤Ã¥ Åä·Ðȸ
<3ºÎ> ¿µ»óÀÇÇк¸Çè°ü·Ã Á¤Ã¥ Åä·Ðȸ
ÁÂÀå: ¿ÀÁÖÇü(°æÈñ´ëÇб³º´¿ø), ÀÌâ¼®(ÀÌÁö¿µ»óÀÇÇаú)
13:30-14:00
ÇâÈÄ ±Þ¿©Á¤Ã¥ÀÇ ·Îµå¸Ê
Á¤Å뿵(º¸°Çº¹ÁöºÎ º¸Çè±Þ¿©°ú)
14:00-14:20
Â÷µî¼ö°¡Á¦, ¿Ö ³íÀǵǾî¾ß Çϴ°¡?
¾ç´Þ¸ð(°µ¿°æÈñ´ëÇб³º´¿ø)
14:20-14:40
ÀǷ῵»ó Ç°Áú°ü¸®¿Í ÀÇ·á ÁúÆò°¡
Á¤½ÂÀº(°¡Å縯ÀÇ´ë ¼¿ï¼º¸ðº´¿ø)
14:40-15:00
Â÷µî¼ö°¡Á¦: ±¸Ã¼Àû ½ÇÇà¹æ¾È°ú ±â¼úÀû ´ë¾È
ÃÖÁØÀÏ(°¡Å縯ÀÇ´ë ¼¿ï¼º¸ðº´¿ø)
15:00-15:40
ÆгÎÅäÀÇ
¾ç´Þ¸ð(°µ¿°æÈñ´ëÇб³º´¿ø), Á¤½ÂÀº(°¡Å縯ÀÇ´ë ¼¿ï¼º¸ðº´¿ø), ÃÖÁØÀÏ(°¡Å縯ÀÇ´ë ¼¿ï¼º¸ðº´¿ø), Á¤Å뿵(º¸°Çº¹ÁöºÎ º¸Çè±Þ¿©°ú)
15:40-16:00
ÈÞ½Ä
<4ºÎ> Ç°Áú°ü¸®: ¿µ»óÀÇÇаú Àü¹®ÀÇÀÇ ¿ªÇÒ
ÁÂÀå: ½Å¸íÁø(¿ï»êÀÇ´ë ¼¿ï¾Æ»êº´¿ø)
16:00-16:20
Ư¼öÀÇ·áÀåºñ Ç°Áú°ü¸®¿¡¼ °Ë»çÀ§¿øÀ¸·Î¼ÀÇ ¿ªÇÒ
¹é»óÇö(¼øõÇâÀÇ´ë ºÎõº´¿ø)
16:20-16:50
ºñÀü¼Ó ¿µ»óÀÇÇаú ÀÇ»çÀÇ ¹®Á¦Á¡°ú ÇØ°á¹æ¾È
ÀÌÀºÇý(¼øõÇâÀÇ´ë ºÎõº´¿ø)
16:50-17:00
Q&A
¨ê Evidence-Based Medicine (6¿ù 25ÀÏ Åä¿äÀÏ 09:00-12:10, ÄÚ´Ò¸®¾Æ)
<1ºÎ> ±Ù°Å±â¹Ý ÀÓ»ó¿µ»ó °¡À̵å¶óÀÎ
ÁÂÀå: ¹éÁ¤È¯(¿ï»êÀÇ´ë ¼¿ï¾Æ»êº´¿ø)
09:00-09:25
¿µ»ó°Ë»ç ÀÇ·Ú °¡À̵å¶óÀÎ °³¹ß °æ°ú º¸°í
Á¤¿ì°æ(¼º±Õ°üÀÇ´ë »ï¼º¼¿ïº´¿ø)
09:20-09:50
Áø·áÁöħÀÇ Àû¿ë¼º Æò°¡ÀÇ ¹æ¹ý°ú ÀÇÀÇ
Ãֹ̿µ(Çѱ¹º¸°ÇÀǷῬ±¸¿ø)
09:50-10:30
ÁöÁ¤Åä·Ð
ÀÌ¸í¼®(¼¿ï½Ã¸³ º¸¶ó¸Åº´¿ø), ½Å»ó¼ö(Àü³²´ëÇб³º´¿ø), ¹Ú¸Í·Ä(¾ç»êºÎ»ê´ëÇб³º´¿ø)
10:30-10:50
ÈÞ½Ä
<2ºÎ> °©»ó¼± °áÀý Áø·á ±Ç°í¾È
ÁÂÀå: ÀÌÁØÇü(µ¿¾Æ´ëÇб³º´¿ø), Á¶¼ºÈÖ(°¿ø´ëÇб³º´¿ø)
10:50-11:10
US diagnosis and K-TIRADS
³ªµ¿±Ô(ÈÞ¸Õ¿µ»óÀÇÇм¾ÅÍ)
11:10-11:30
Risk stratification of cervical lymph nodes
±èÁöÈÆ(¼¿ï´ëÇб³º´¿ø)
11:30-11:50
Non-surgical ablation therapy (RFA, EA)
¹éÁ¤È¯(¿ï»êÀÇ´ë ¼¿ï¾Æ»êº´¿ø)
11:50-12:10
Åä·Ð
¨ë ¸â¹ö½Ê¼ÒÀ§¿øȸ ¿öÅ©¼¥ (6¿ù 25ÀÏ Åä¿äÀÏ 09:00-12:00, ¸®¿À¸¶Á¶·¹)
<1ºÎ> ȸ¿øÀÇ ºÐ·ù ¹× ±ÇÀÍ¿¡ °üÇÑ ÀÇ°ß °øÀ¯
ÁÂÀå: ±èÀÇÁ¾(°æÈñ´ëÇб³º´¿ø)
09:00-09:15
´ëÇÑ¿µ»óÀÇÇÐȸ ȸ¿ø ºÐ·ù ¹× ±ÇÀÍ ÇöȲ
±èÀ±Çö(Àü³²´ëÇб³º´¿ø)
09:15-09:35
°³¿øÀÇ ¹× ºÀÁ÷ÀǸ¦ À§ÇÑ ±ÇÀÍÁõÁø ¹æ¾È
ÀÌâ¼®(ÀÌÁö¿µ»óÀÇÇаú)
09:35-09:55
¼ö·ÃÀÇ ¹× ÀüÀÓÀǸ¦ À§ÇÑ ±ÇÀÍÁõÁø ¹æ¾È
¹Ú½ÂÇö(¿¬¼¼ÀÇ´ë ¼¼ºê¶õ½ºº´¿ø)
09:55-10:15
»êÇÏÇÐȸ¿Í ¿µ»óÀÇÇÐȸ¸¦ ¿¬°èÇÑ È¸¿ø°ü¸®
ÃÖÁø¿µ(¿¬¼¼ÀÇ´ë ¼¼ºê¶õ½ºº´¿ø)
10:15-10:35
ÇÐȸ¿Í ȸ¿øÀÇ ¼ÒÅë °È ¹æ¾È
õÁ¤Àº(¼¿ï´ëÇб³º´¿ø)
10:35-10:50
ÈÞ½Ä
<2ºÎ> ȸ¿ø Æò»ý±³À°ÇÁ·Î±×·¥ ±¸ÃàÀ» À§ÇÑ Áغñ
ÁÂÀå: ÀÌ¿øÀç(¼º±Õ°úÀÇ´ë »ï¼º¼¿ïº´¿ø)
10:50-11:00
ȸ¿ø ¼³¹®Á¶»ç °á°ú º¸°í
±èÀÇÁ¾(°æÈñ´ëÇб³º´¿ø)
11:00-11:40
À§¿øȸº° ¹ßÁ¦ ÅäÀÇ
±èÀ±Çö(Àü³²´ëÇб³º´¿ø), À̽±¸(¿¬¼¼ÀÇ´ë ¼¼ºê¶õ½ºº´¿ø), À̽¼ö(¿ï»êÀÇ´ë ¼¿ï¾Æ»êº´¿ø), Á¦È¯ÁØ(¼¿ï´ëÇб³º´¿ø)
11:40-12:00
ÆгÎÅäÀÇ
±¸Áø¸ð(¼¿ï´ëÇб³º´¿ø), ÀÌÁ¦Èñ(¾ÆÁÖ´ëÇб³º´¿ø), Á¶¿µÁØ(°Ç¾ç´ëÇб³º´¿ø), ÃÖÁø¿µ(¿¬¼¼ÀÇ´ë ¼¼ºê¶õ½ºº´¿ø)
¨í Molecular Imaging ¿¬¼ö°Á (6¿ù 25ÀÏ Åä¿äÀÏ 13:30-17:00, ¸®¿À¸¶Á¶·¹)
<1ºÎ> ÁÂÀå: ¹®Ä¡¿õ(ÀÎÁ¦ÀÇ´ë ÀÇ¿ë°øÇкÎ)
14:30-14:50
Molecular Imaging: Concept, Methodologies, Strategies
ÀÌÁ¤Èñ(¼º±Õ°üÀÇ´ë »ï¼º¼¿ïº´¿ø)
14:50-15:10
Contrast Agents: Nanochemistry for Molecular Imaging
ÀÌÀμö(Æ÷Ç×°ø°ú´ëÇб³)
15:10-15:30
Gadolinium Agents for MR Molecular Imaging: Small Molecule to Nanoparticle
Àå¿ë¹Î(°æºÏ´ëÇб³º´¿ø)
15:30-15:50
Cellular Imaging
ÃÖÀ±¼®(¿ï»êÀÇ´ë ¼¿ï¾Æ»êº´¿ø)
15:50-16:20
ÈÞ½Ä
<2ºÎ> ÁÂÀå: ÀÌÁ¤Èñ(¼º±Õ°üÀÇ´ë »ï¼º¼¿ïº´¿ø)
16:20-16:40
Integrative Molecular Imaging of MicroRNAs
±è¼øÇÐ(°¡Å縯°üµ¿´ëÇб³ ±¹Á¦¼º¸ðº´¿ø)
16:40-17:00
Application of Radiogenomics in Oncology
ÃÖ½ÂÈ«(¼¿ï´ëÇб³º´¿ø)
17:00-17:20
Imaging of Theragnostics: Targeted Imaging with DDS
Çã¿ë¹Î(¿¬¼¼ÀÇ´ë ¼¼ºê¶õ½ºº´¿ø)
17:20-17:40
Emerging Molecular imaging approach: Hyperpolarized 13 C MRS/MRSI
ÀÌÁؼº(¼º±Õ°ü´ëÇб³ ³ú°úÇÐÀ̹Ì¡¿¬±¸´Ü)
17:40-18:00
Molecular imaging using CEST MRI
Á¶ÁöÇö(±âÃÊ°úÇÐÁö¿ø¿¬±¸¿ø)
¨ð Áõ·Ê¸¦ ÅëÇÑ À¯¹æ¿µ»ó Æǵ¶ (6¿ù 26ÀÏ ÀÏ¿äÀÏ 09:00-12:00, ¸óÅ׷μÒ)
<1ºÎ> Breast Imaging ¥°
ÁÂÀå: ±è±Ý¿ø(°Ç¾ç´ëÇб³º´¿ø), ±èÀ¯¹Ì(´Ü±¹´ëÇб³º´¿ø)
09:00-09:20
Mammography °ÀÇ
½ÅÈñÁ¤(¿ï»êÀÇ´ë ¼¿ï¾Æ»êº´¿ø)
09:20-09:40
Mammography Áõ·Ê ¥°
ÀÌ ¾È(¼¿ï´ëÇб³º´¿ø)
09:40-10:00
Mammography Áõ·Ê ¥±
±èÁøÀ¯(ºÎ»ê´ëÇб³º´¿ø)
10:00-10:20
Extramammary Lesions
Àå¹ÌÁ¤(ºÐ´ç¼¿ï´ëÇб³º´¿ø)
10:20-10:40
ÈÞ½Ä
<2ºÎ> Breast Imaging ¥±
ÁÂÀå: ±èÇý¿ø(¿ø±¤´ëÇб³º´¿ø), ÇѺΰæ(¼º±Õ°üÀÇ´ë »ï¼º¼¿ïº´¿ø)
10:40-11:00
Breast US °ÀÇ
±è¼÷Á¤(ÀÎÁ¦ÀÇ´ë ÇØ¿î´ë¹éº´¿ø)
11:00-11:20
Breast US Áõ·Ê ¥°
ÀÌÁøÈ(µ¿¾Æ´ëÇб³º´¿ø)
11:20-11:40
Breast US Áõ·Ê ¥±
ÃÖÇý¿µ(°æ»ó´ëÇб³º´¿ø)
11:40-12:00
Incidental Breast Lesions on Other Imaging Modalities
¹Ú¿µ¹Ì(ÀÎÁ¦ÀÇ´ë ºÎ»ê¹éº´¿ø)
¨ñ Essentials on Cardiac CT -How to Do and How to Read Cardiac CT (6¿ù 26ÀÏ ÀÏ¿äÀÏ 09:00-12:00, ¸¶³ª·Ñ¶ó)
<1ºÎ> How to Perform the Cardiac CT
ÁÂÀå: Á¶¿µÁØ(°Ç¾ç´ëÇб³º´¿ø), ÃÖ»óÀÏ(ºÐ´ç¼¿ï´ëÇб³º´¿ø)
09:00-09:20
How to Start Cardiac CT & Patient Preparation
±èÁ¤¾Æ(ÀÎÁ¦ÀÇ´ë ÀÏ»ê¹éº´¿ø)
09:20-09:50
Scan Protocol Optimization
¹Úöȯ(¿¬¼¼ÀÇ´ë °³²¼¼ºê¶õ½ºº´¿ø)
09:50-10:00
ÈÞ½Ä
<2ºÎ> Read with Experts
ÁÂÀå: ÀÌ È°(¼¿ï´ëÇб³º´¿ø), Áø°ø¿ë(ÀüºÏ´ëÇб³º´¿ø)
10:00-10:15
Coronary Artery Disease
À̹迵(°¡Å縯ÀÇ´ë ¼º¹Ù¿À·Îº´¿ø)
10:15-10:30
Myocardial and Pericardial Disease
ÀüÀºÁÖ(ºÐ´ç¼¿ï´ëÇб³º´¿ø)
10:30-10:45
Valvular Heart Valve Disease
°ÁØ¿ø(¿ï»êÀÇ´ë ¼¿ï¾Æ»êº´¿ø)
10:45-11:00
Adult Congenital Heart Disease
±¸Çö¿ì(¿ï»êÀÇ´ë ¼¿ï¾Æ»êº´¿ø)
11:00-11:10
ÈÞ½Ä
<3ºÎ> Cardiac CT Á¤Ã¥ Åä·Ð
ÁÂÀå: ÀÌÁ¾¹Î(°æºÏ´ëÇб³º´¿ø)
11:10-12:00
Åä·Ð
±èÅÂÈÆ(¿¬¼¼ÀÇ´ë °³²¼¼ºê¶õ½ºº´¿ø), ÀÌ Çå(¼øõÇâÀÇ´ë ºÎõº´¿ø), ÀÌ È°(¼¿ï´ëÇб³º´¿ø), Á¤Á¤ÀÓ(°¡Å縯ÀÇ´ë ¼¿ï¼º¸ðº´¿ø), ÃÖº´¿í(¿¬¼¼ÀÇ´ë ¼¼ºê¶õ½ºº´¿ø)
¨ò Àǹ«À§¿øȸ ½ÉÆ÷Áö¾ö -Á¶¿µÁ¦ »ç¿ë °¡À̵å¶óÀΰú ¿µ»óÀÇÇаú ÀÇ·á °¨Á¤ (6¿ù 26ÀÏ ÀÏ¿äÀÏ 09:00-12:00, º£¸£³ªÂ÷)
<1ºÎ> Á¶¿µÁ¦ »ç¿ë °¡À̵å¶óÀÎ
ÁÂÀå: ±èÀ±Çö(Àü³²´ëÇб³º´¿ø)
09:00-09:20
Newly released guideline for contast media
ÃÖ¿µÈÆ(¼¿ï´ëÇб³º´¿ø)
09:20-09:40
FAQ for contrast agents in daily practice
ÃÖÇõÀç(°¿ø´ëÇб³º´¿ø)
09:40-10:10
Á¶¿µÁ¦ °ú¹Î¹ÝÀÀÀÇ ÀÓ»óÀû ´ëó¿Í °ü¸® ½Ã½ºÅÛ ¼Ò°³
°Çý·Ã(¼¿ïÀÇ´ë ³»°ú)
10:10-10:30
Á¶¿µÁ¦ °ü·Ã ÀÇ·á ¼Ò¼Û
±ÇÁ¾¿ø(¼º±Õ°üÀÇ´ë »ï¼º¼¿ïº´¿ø)
10:30-10:40
Q&A
10:40-10:50
ÈÞ½Ä
<2ºÎ> ¿µ»óÀÇÇаú °ü·Ã ÀÇ·á ¼Ò¼Û : ½Ç·Ê¸¦ ÅëÇÑ Á¢±Ù
ÁÂÀå: ÀבּÇ(°¡Å縯ÀÇ´ë ¼ººó¼¾Æ®º´¿ø)
10:50-11:05
ôÃß °ü·Ã ÀÇ·áºÐÀï »ç¾È
¹ÚÈñÁø(¼º±Õ°üÀÇ´ë °ºÏ»ï¼ºº´¿ø)
11:05-11:20
±Ù°ñ°Ý°è °ü·Ã ÀÇ·áºÐÀï »ç¾È
Á¤ÁØ¿ë(°¡Å縯ÀÇ´ë ¼¿ï¼º¸ðº´¿ø)
11:20-11:35
º¹ºÎ¿µ»ó °ü·Ã ÀÇ·áºÐÀï »ç¾È
Á¤¿ëÀº(¿¬¼¼ÀÇ´ë °³²¼¼ºê¶õ½ºº´¿ø)
11:35-11:50
ÁßÀç ½Ã¼ú °ü·Ã ÀÇ·áºÐÀï »ç¾È
±è¿µÈ¯(°è¸íÀÇ´ë µ¿»êÀÇ·á¿ø)
11:50-12:00
Q&A
¨ó Precision Medicine (6¿ù 26ÀÏ ÀÏ¿äÀÏ 09:00-11:00, ÄÚ´Ò¸®¾Æ)
ÁÂÀå: ÀÓÅÂȯ(¿ï»êÀÇ´ë ¼¿ï¾Æ»êº´¿ø)
09:00-09:30
Precision medicineÀ̶õ?
ÀÌÁö¿(°¡Å縯¾Ï¿¬±¸¼ÒÀå, °¡Å縯ÀÇ´ë ¼¿ï¼º¸ðº´¿ø ºñ´¢±â°ú)
09:30-10:00
Genomics´Â ¹«¾ùÀΰ¡?
¹Ú¿õ¾ç(»ï¼ºÀ¯Àüü¿¬±¸¼ÒÀå, ¼º±Õ°üÀÇ´ë »ýÈÇб³½Ç)
10:00-10:30
Precision medicine¿¡¼ RadiologyÀÇ ¿ªÇÒ
ÃÖ½ÂÈ«(¼¿ï´ëÇб³º´¿ø)
10:30-11:00
Q&A